GNG7 and neoplasm: Moreover, GNG7 may also be involved in the modulation of immune checkpoint pathways, such as the PD-1/PD-L1 axis (35, 36), indirectly enhancing T cell activity by reducing tumor-induced immune suppression (37, 38).